Hospital 12 de Octubre 2025 Highlights
- Santiago Ponce assumes the role of Head of Therapeutic Innovation and Precision Medicine, bringing a wealth of experience to the forefront of cancer care.
- Ponce's foundation includes a medical degree from the Universidad de Navarra and a Master's in Molecular Oncology from the CNIO in Madrid.
- Ponce transitioned to the Instituto gustave Roussy Cancer Center in Paris.
Dr. Santiago Ponce Leads Innovation in Precision Medicine
Table of Contents
- Dr. Santiago Ponce Leads Innovation in Precision Medicine
- Dr. Santiago Ponce: Revolutionizing Cancer Treatment Through Precision Medicine – Q&A
- What is Precision Medicine and How does Dr. Ponce Use It?
- What are Dr. Ponce’s areas of Expertise?
- Where has Dr. Ponce Worked?
- What is Dr.Ponce’s Background?
- What is Dr. Ponce’s Contribution to Clinical Trials and research?
- What Role Does the OncoSur Foundation Play in Dr. Ponce’s Work?
- What is the importance of Dr. ponce becoming Head of Therapeutic Innovation and Precision Medicine?
- How can precision medicine improve lung cancer outcomes?
- Who is Dr. Luis Paz-Ares?
- Key Roles and Responsibilities Summary
Published: 2025-02-05
A New Era in Cancer Treatment
Dr. Santiago Ponce assumes the role of Head of Therapeutic Innovation and Precision Medicine, bringing a wealth of experience to the forefront of cancer care. His expertise spans from lung cancer to targeted therapies and the advancement of novel drugs.
Academic and early Career Highlights
dr. Ponce’s foundation includes a medical degree from the Universidad de Navarra and a Master’s in Molecular Oncology from the CNIO in Madrid. from 2009 to 2020, he played a pivotal role at Hospital 12 de Octubre, coordinating the Thoracic Tumors Unit alongside Dr. Luis Paz-Ares. Together, he led the Early Stages Unit, where he also established the Molecular Tumor Committee.
International Leadership at Gustave Roussy
In 2020, Dr. Ponce transitioned to the Instituto gustave Roussy Cancer Center in Paris. There, he served as Head of the Department of Therapeutic Innovation and Early Stages, Director of the Precision Medicine Program, and ultimately, Deputy director of clinical Research.
Extensive Research and Clinical Trial Experience
Dr. Ponce’s commitment to advancing cancer treatment is evident in his extensive research background. He has been the principal investigator in over 200 Phase I, II, and III clinical trials. His contributions extend to numerous publications in high-impact scientific journals.
Contributions to the Field
Dr. Ponce is an active member of various medical societies and serves as the scientific coordinator of the OncoSur Foundation, which focuses on medical training and independent clinical research. His specialization includes:
- Lung cancer
- Targeted therapies
- Development of new drugs
Quote
Dr. Ponce’s work is characterized by a dedication to innovation and precision. As stated, he is “especializado en cáncer de pulmón, terapias dirigidas y el desarrollo de nuevos fármacos.”
Dr. Santiago Ponce: Revolutionizing Cancer Treatment Through Precision Medicine – Q&A
Published: 2025-03-12
this article explores the innovative work of Dr. Santiago Ponce in precision medicine and oncology, answering key questions about his contributions to cancer treatment.
What is Precision Medicine and How does Dr. Ponce Use It?
Precision medicine is an approach to disease treatment and prevention that considers individual variability in genes,environment,and lifestyle for each person. Dr. Santiago Ponce is a leading expert in applying precision medicine techniques to oncology, notably in lung cancer treatment. He utilizes genomic data and other biomarkers to tailor treatment plans specifically to each patient’s unique cancer profile.
What are Dr. Ponce’s areas of Expertise?
Dr. Ponce specializes in:
Lung Cancer: He is deeply involved in researching and treating various types of lung cancer, utilizing the latest advancements in diagnostics and therapeutics.
Targeted Therapies: Dr. Ponce focuses on developing and applying targeted therapies that precisely attack cancer cells while minimizing harm to healthy cells.
New Drug Growth: He actively participates in the development and clinical trials of novel drugs aimed at improving cancer treatment outcomes.
Where has Dr. Ponce Worked?
Dr. Ponce has held notable positions at renowned medical institutions:
Hospital 12 de Octubre (Madrid, Spain): From 2009 to 2020, he coordinated the Thoracic Tumors Unit and led the Early Stages Unit alongside dr. Luis Paz-Ares.
Gustave Roussy Cancer Center (Paris, France): In 2020, he served as Head of the Department of Therapeutic Innovation and Early Stages, Director of the Precision Medicine Program, and Deputy Director of Clinical Research.
What is Dr.Ponce’s Background?
Dr. Ponce’s extensive education includes:
Medical Degree from the Universidad de Navarra
Master’s in Molecular Oncology from the CNIO in madrid
What is Dr. Ponce’s Contribution to Clinical Trials and research?
Dr. Ponce has been the principal investigator in over 200 Phase I, II, and III clinical trials, demonstrating his dedication to advancing cancer treatment through rigorous scientific examination. He has also contributed to numerous publications in high-impact scientific journals.
What Role Does the OncoSur Foundation Play in Dr. Ponce’s Work?
Dr. ponce serves as the scientific coordinator of the OncoSur Foundation, an association dedicated to medical training and self-reliant clinical research in oncology.
What is the importance of Dr. ponce becoming Head of Therapeutic Innovation and Precision Medicine?
Dr. Ponce’s appointment signifies a renewed focus on personalized cancer treatments, leveraging his deep expertise in targeted therapies and novel drug development to improve patient outcomes.
How can precision medicine improve lung cancer outcomes?
Precision medicine allows doctors to understand the individual genetic and molecular makeup of a patient’s tumor. This understanding allows them to select treatments that are most likely to be effective and avoid treatments that are unlikely to work or that could cause unnecessary side effects.
Who is Dr. Luis Paz-Ares?
Dr. Luis Paz-Ares is a prominent oncologist who worked alongside Dr.Ponce at Hospital 12 de Octubre. Together, they coordinated the thoracic Tumors Unit and led the Early Stages Unit, establishing the Molecular Tumor Committee.
**
Key Roles and Responsibilities Summary
| Role | Institution | Location |
| ——————————————————– | —————————————————————— | —————- |
| Head of Therapeutic Innovation and Precision Medicine | Current Role | |
| Head of Department of Therapeutic Innovation & Early Stages | Instituto Gustave Roussy Cancer Center | Paris,France |
| Director of Precision Medicine Program | Instituto Gustave Roussy Cancer Center | Paris,France |
| Deputy Director of Clinical Research | Instituto Gustave Roussy Cancer Center | Paris,France |
| Coordinator of Thoracic Tumors Unit | Hospital 12 de Octubre | Madrid,Spain |
| Leader of Early Stages Unit | Hospital 12 de Octubre | Madrid,Spain |
| Scientific Coordinator | OncoSur Foundation | |